- CSIR-IIIM Jammu is all set to lead India’s first cannabis medicine project, a pioneering initiative by Prime Minister Narendra Modi.
- ThisCannabis Medicine project, initiated in collaboration with Canadian firm IndusScan, aims to explore the medicinal potential of cannabis to benefit patients with neuropathy, cancer and epilepsy, known for its abuse potential.
CSIR-IIIM
- It is located in Jammu, India, and is a part of the Council of Scientific and Industrial Research (CSIR).
- CSIR-IIIM focuses on research in medicinal chemistry, natural products, herbal medicines, drug discovery and integrative medicine.
- The institute aims to develop innovative solutions to health challenges by combining traditional knowledge with modern scientific techniques.
- CSIR-IIIM collaborates with national and international research organisations, academic institutions and pharmaceutical companies to further its research goals and contribute to India’s scientific progress and healthcare sector.
- Chief Scientist, CSIR-IIIM Jammu – Dr. Zabir Ahmed
Medical Cannabis
- The FDA approved cannabis-derived drugs such as Marinol/Nabilone and Cesamet to effectively manage nausea and vomiting in patients.
- Sativex, another FDA-approved drug, uses cannabis to treat neuropathic pain and spasms, bringing relief to those suffering from these conditions.
- Epidiolex containing cannabidiol has shown promising results in the treatment of epilepsy, offering new possibilities for patients with the condition.
- Besides the United States, other countries are also exploring various medical applications of cannabis, taking advantage of its potential to treat various health conditions.]